Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Net Cash Flow: 2019-2025

Historic Net Cash Flow for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $46.9 million.

  • Benitec Biopharma's Net Cash Flow fell 115.45% to -$5.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $46.9 million, marking a year-over-year decrease of 3.26%. This contributed to the annual value of $46.9 million for FY2025, which is 3.26% down from last year.
  • Per Benitec Biopharma's latest filing, its Net Cash Flow stood at $46.9 million for FY2025, which was down 3.26% from $48.4 million recorded in FY2024.
  • Benitec Biopharma's 5-year Net Cash Flow high stood at $48.4 million for FY2024, and its period low was -$15.9 million during FY2022.
  • For the 3-year period, Benitec Biopharma's Net Cash Flow averaged around $31.1 million, with its median value being $46.9 million (2025).
  • As far as peak fluctuations go, Benitec Biopharma's Net Cash Flow tumbled by 268.05% in 2022, and later surged by 2,524.77% in 2024.
  • Over the past 5 years, Benitec Biopharma's Net Cash Flow (Yearly) stood at $9.5 million in 2021, then plummeted by 268.05% to -$15.9 million in 2022, then spiked by 87.44% to -$2.0 million in 2023, then spiked by 2,524.77% to $48.4 million in 2024, then decreased by 3.26% to $46.9 million in 2025.